Emerging hypotheses on the pathophysiology of vaccine-associated thromboembolic events include molecular mimicry between vaccine components and endogenous proteins, immune complex formation involving platelet factor 4 (PF4), complement activation, and endothelial dysfunction induced by spike protein expression. Here, PF4 is linked to endothelial dysfunction.